Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Cash from Financing Activities (2016 - 2026)

Collegium Pharmaceutical has reported Cash from Financing Activities over the past 10 years, most recently at -$21.8 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities rose 47.14% year-over-year to -$21.8 million; the TTM value through Dec 2025 reached -$110.2 million, down 81.91%, while the annual FY2025 figure was -$110.2 million, 81.91% down from the prior year.
  • Cash from Financing Activities for Q4 2025 was -$21.8 million at Collegium Pharmaceutical, down from -$14.8 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $517.8 million in Q1 2022 and troughed at -$114.2 million in Q2 2024.
  • A 5-year average of $1.8 million and a median of -$26.2 million in 2021 define the central range for Cash from Financing Activities.
  • Biggest five-year swings in Cash from Financing Activities: crashed 242.64% in 2021 and later surged 4614.86% in 2022.
  • Year by year, Cash from Financing Activities stood at -$42.5 million in 2021, then skyrocketed by 39.24% to -$25.8 million in 2022, then crashed by 162.66% to -$67.8 million in 2023, then surged by 39.14% to -$41.3 million in 2024, then surged by 47.14% to -$21.8 million in 2025.
  • Business Quant data shows Cash from Financing Activities for COLL at -$21.8 million in Q4 2025, -$14.8 million in Q3 2025, and -$48.4 million in Q2 2025.